Santhera We are a specialty pharmaceutical company based in Switzerland committed to development and commercialization of innovative medicines to meet the needs of patients living with rare diseases. Read more >>

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company committed to developing and commercializing innovative medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs.

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and pulmonary diseases with high unmet medical need.

Find the latest Santhera Pharmaceuticals Holding AG (SANN.SW) stock quote, history, news and other vital information to help you with your stock trading and investing.

2022年1月4日 · Santhera的主要产品管线包括目前正在开展治疗DMD关键临床试验的Vamorolone，和处于临床阶段的治疗囊性纤维化及其他中性粒细胞肺病的Lonodelestat，以及一款治疗先天性肌营养不良的探索性基因疗法。

曙方医药是一家专注于中国罕见病新药研发和商业化的创新型企业，致力于为中国罕见病患者提供具有临床可及性的产品，为罕见病治疗药物提供具有成功前景的商业解决方案。

2025年3月28日 · Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Are you looking for an exciting opportunity to make a difference? If so, Santhera is your place to perform and grow. If you identify with the Santhera spirit, please review current job openings and submit your profile.

5 天之前 · Get Santhera Pharmaceuticals Holding AG (SANN.S) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Wir bei Santhera haben uns der Entwicklung von Therapieoptionen für Patienten mit seltenen Erkrankungen verschrieben – unser Schwerpunkt liegt dabei auf neuromuskulären Erkrankungen, die besonders schwere Auswirkungen auf das Leben …